BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership100.5%-1.92 pts vs. prior quarter
Institutions holding535+20 vs. prior quarter
Insider trades (recent)19 buys / 25 sellsNet selling
Short interest10.29% of floatDays to cover 12.2 · as of 30 Oct 2026
Short-sale volume share21.8%5-day average of daily volume

Short-sale volume as % of daily volume

12%20%27%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.77M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$7.0MSuper−$778.9KBig−$6.4MMid−$11.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 46.5% of shares outstanding.

Largest holders

  • FMR14.98%
  • BlackRock12.12%
  • Avoro Capital Advisors LLC9.75%
  • Suma Krishnan4.87%
  • Krish Krishnan4.81%
  • State Street Global Advisors4.79%
  • Vanguard Portfolio Management, LLC4.34%
  • Vanguard Capital Management, LLC4.04%

By investor type

  • Mutual Fund74.57%
  • Hedge Fund17.36%
  • Individual/Insider9.93%
  • Public Company2.89%
  • VC/PE Fund2.15%
  • Private Company1.18%
  • Sovereign Wealth Fund0.89%
  • Government Pension Fund0.82%

Reported short interest has fallen from 10.83% to 10.29% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Geode Capital Management, LLC Mutual Fund 2026/Q3 +112,742 2.7%
Franklin Resources Mutual Fund 2026/Q3 +109,034 1.3%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +105,316 0.4%
State Street Global Advisors Mutual Fund 2026/Q3 +68,969 4.8%
ACT Capital Management Hedge Fund 2026/Q3 +42,000 0.3%
Ranger Investment Management, L.P. Mutual Fund 2026/Q3 +36,557 0.1%
Barclays PLC Public Company 2026/Q3 +35,938 0.1%
Fiera Capital Corporation Mutual Fund 2026/Q3 +35,501 0.2%
JPMorgan Chase & Co. Public Company 2026/Q3 +28,713 0.1%
Retirement Systems Of Alabama Government Pension Fund 2026/Q3 +27,476 0.1%
ClearBridge Investments, LLC Mutual Fund 2026/Q3 +24,600 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +24,463 0.2%
BlackRock Mutual Fund 2026/Q3 +240,976 14.1%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +202,326 2.3%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +168,454 2.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Dino Rossi Independent Director Other Disposition -3,500 – 46,500
13 Sep 2026 Daniel Janney Lead Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 Daniel Janney Lead Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
13 Sep 2026 Dino Rossi Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 Dino Rossi Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
13 Sep 2026 Julian Gangolli Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 Julian Gangolli Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
13 Sep 2026 E. Sutherland Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 E. Sutherland Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
13 Sep 2026 Christopher Mason Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 Christopher Mason Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
13 Sep 2026 Catherine Mazzacco Independent Director Other Derivative Acquisition +471 – 471
13 Sep 2026 Catherine Mazzacco Independent Director Other Derivative Acquisition +1,187 $340.03 1,187
3 Sep 2026 Krish Krishnan Chairperson & CEO Automatic Disposition -520 $354.54 1,425,253
3 Sep 2026 Krish Krishnan Chairperson & CEO Open Market Disposition -24,480 $366.56 1,425,253
3 Sep 2026 Suma Krishnan Founder, President of R&D and Director Automatic Disposition -520 $354.54 1,443,155
3 Sep 2026 Suma Krishnan Founder, President of R&D and Director Open Market Disposition -24,480 $366.56 1,443,155
13 Aug 2026 Dino Rossi Independent Director Other Disposition -3,691 – 50,000
13 Aug 2026 Dino Rossi Independent Director Open Market Disposition -25,000 $333.23 50,000
24 Jun 2026 John Thomas EVP, General Counsel & Corporate Secretary Derivative Exercise and Sale -1,000 $347.27 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,044,878 10.3% 12.2
15 Oct 2026 2,936,047 9.9% 10.3
30 Sep 2026 3,475,527 11.7% 11.2
15 Sep 2026 3,163,642 10.7% 13.2
31 Aug 2026 3,347,813 11.3% 15.3
14 Aug 2026 3,204,909 10.8% 10.3

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top